Literature DB >> 20006605

The human IFN-inducible p53 target gene TRIM22 colocalizes with the centrosome independently of cell cycle phase.

Jessica Petersson1, Per Lönnbro, Anna-Maria Herr, Matthias Mörgelin, Urban Gullberg, Kristina Drott.   

Abstract

TRIM22 (Staf50), a member of the TRIM protein family, is an interferon (IFN)-inducible protein as well as a p53 target gene. The function of TRIM22 is largely unknown, but TRIM22 is suggested to play a role in viral defense by restriction of viral replication. In addition, TRIM22 may function as a ubiquitin E3 ligase. In contrast to previous reports showing solely cytoplasmic localization of exogenous TRIM22, we report here that endogenous TRIM22 is localized to both nucleus and cytosol in primary human mononuclear cells, as well as in the human osteosarcoma cell line U2OS. Moreover, we demonstrate a colocalization of TRIM22 with the centrosomes in primary cells as well as in U2OS cells, and show that this colocalization is independent of cell cycle phase. Additionally, our data suggest the colocalization with centrosomes to be independent on the microtubule network. Given that some viral protein assembly takes place in the close vicinity of the centrosome, our data suggest that important functions of TRIM22 such as regulation of viral replication and protein degradation may take place in the centrosome. However, further studies are warranted to certify this notion. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20006605     DOI: 10.1016/j.yexcr.2009.12.007

Source DB:  PubMed          Journal:  Exp Cell Res        ISSN: 0014-4827            Impact factor:   3.905


  12 in total

1.  TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.

Authors:  Anna Kajaste-Rudnitski; Sara S Marelli; Cinzia Pultrone; Thomas Pertel; Pradeep D Uchil; Nadir Mechti; Walther Mothes; Guido Poli; Jeremy Luban; Elisa Vicenzi
Journal:  J Virol       Date:  2011-02-23       Impact factor: 5.103

Review 2.  TRIM family contribute to tumorigenesis, cancer development, and drug resistance.

Authors:  Ning Huang; Xiaolin Sun; Peng Li; Xin Liu; Xuemei Zhang; Qian Chen; Hong Xin
Journal:  Exp Hematol Oncol       Date:  2022-10-19

3.  TRIM22: A Diverse and Dynamic Antiviral Protein.

Authors:  Clayton J Hattlmann; Jenna N Kelly; Stephen D Barr
Journal:  Mol Biol Int       Date:  2012-05-08

4.  Enterovirus 71 induces degradation of TRIM38, a potential E3 ubiquitin ligase.

Authors:  Xinlei Liu; Xiaobo Lei; Zhuo Zhou; Zhenmin Sun; Qinghua Xue; Jianwei Wang; Tao Hung
Journal:  Virol J       Date:  2011-02-10       Impact factor: 4.099

Review 5.  Tripartite Motif 22 and Class II Transactivator Restriction Factors: Unveiling Their Concerted Action against Retroviruses.

Authors:  Greta Forlani; Roberto S Accolla
Journal:  Front Immunol       Date:  2017-10-18       Impact factor: 7.561

6.  Tripartite Motif-Containing Protein 22 Interacts with Class II Transactivator and Orchestrates Its Recruitment in Nuclear Bodies Containing TRIM19/PML and Cyclin T1.

Authors:  Greta Forlani; Giovanna Tosi; Filippo Turrini; Guido Poli; Elisa Vicenzi; Roberto S Accolla
Journal:  Front Immunol       Date:  2017-05-15       Impact factor: 7.561

Review 7.  E3 Ubiquitin Ligase TRIM Proteins, Cell Cycle and Mitosis.

Authors:  Santina Venuto; Giuseppe Merla
Journal:  Cells       Date:  2019-05-27       Impact factor: 6.600

8.  The p53 target gene TRIM22 directly or indirectly interacts with the translation initiation factor eIF4E and inhibits the binding of eIF4E to eIF4G.

Authors:  Jessica Petersson; Malin Ageberg; Carl Sandén; Tor Olofsson; Urban Gullberg; Kristina Drott
Journal:  Biol Cell       Date:  2012-05-31       Impact factor: 4.458

9.  Interferon alpha (IFNα)-induced TRIM22 interrupts HCV replication by ubiquitinating NS5A.

Authors:  Chen Yang; Xinhao Zhao; Dakang Sun; Leilei Yang; Chang Chong; Yu Pan; Xiumei Chi; Yanhang Gao; Moli Wang; Xiaodong Shi; Haibo Sun; Juan Lv; Yuanda Gao; Jin Zhong; Junqi Niu; Bing Sun
Journal:  Cell Mol Immunol       Date:  2015-02-16       Impact factor: 11.530

10.  Efficient Gene Knockdown in Mouse Oocytes through Peptide Nanoparticle-Mediated SiRNA Transfection.

Authors:  Zhen Jin; Ruichao Li; Chunxiang Zhou; Liya Shi; Xiaolan Zhang; Zhixia Yang; Dong Zhang
Journal:  PLoS One       Date:  2016-03-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.